Kallioniemi OP - Search Results

1

Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.

Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M. Forus A, et al. Among authors: kallioniemi op. Oncogene. 2001 Oct 18;20(47):6881-90. doi: 10.1038/sj.onc.1204874. Oncogene. 2001. PMID: 11687967

2

Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA. Skotheim RI, et al. Among authors: kallioniemi op. Neoplasia. 2003 Sep-Oct;5(5):397-404. doi: 10.1016/s1476-5586(03)80042-8. Neoplasia. 2003. PMID: 14670177 Free PMC article.

3

Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization.

Grigoryan AM, Dougherty ER, Kononen J, Bubendorf L, Hostetter G, Kallioniemi O. Grigoryan AM, et al. J Biomed Opt. 2002 Jan;7(1):109-22. doi: 10.1117/1.1428292. J Biomed Opt. 2002. PMID: 11818019 Free article.

4

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT. Leotlela PD, et al. Among authors: kallioniemi op. Oncogene. 2007 May 31;26(26):3846-56. doi: 10.1038/sj.onc.1210155. Epub 2006 Dec 11. Oncogene. 2007. PMID: 17160014

5

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.

Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS. Weeraratna AT, et al. Among authors: kallioniemi op. Oncogene. 2004 Mar 18;23(12):2264-74. doi: 10.1038/sj.onc.1207337. Oncogene. 2004. PMID: 14755246

6

Biochip technologies in cancer research.

Kallioniemi OP. Kallioniemi OP. Ann Med. 2001 Mar;33(2):142-7. doi: 10.3109/07853890109002069. Ann Med. 2001. PMID: 11327117 Review.

7

High frequency of BRAF mutations in nevi.

Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. Pollock PM, et al. Nat Genet. 2003 Jan;33(1):19-20. doi: 10.1038/ng1054. Epub 2002 Nov 25. Nat Genet. 2003. PMID: 12447372

8

[From gene chips to biochips: challenges and possibilities of the new biotechnology].

Kallioniemi O. Kallioniemi O. Duodecim. 2002;118(11):1149-56. Duodecim. 2002. PMID: 12239848 Review. Finnish. No abstract available.

9

Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.

Rökman A, Baffoe-Bonnie AB, Gillanders E, Fredriksson H, Autio V, Ikonen T, Gibbs KD Jr, Jones M, Gildea D, Freas-Lutz D, Markey C, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Trent J, Bailey-Wilson JE, Schleutker J. Rökman A, et al. Among authors: kallioniemi op. Hum Genet. 2005 Jan;116(1-2):43-50. doi: 10.1007/s00439-004-1214-7. Epub 2004 Nov 11. Hum Genet. 2005. PMID: 15549392

10

Linking chromosomal clues.

Kallioniemi OP. Kallioniemi OP. Nat Genet. 1997 Jan;15(1):5-6. doi: 10.1038/ng0197-5. Nat Genet. 1997. PMID: 8988157 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page